
Merck's Dr Dave Maraldo explains that small-molecule platform agility and flexible conjugation capacity can help biologics manufacturing respond to research needs.
Bas Trietsch, chief technology officer, MIMETAS, discusses the successes he's encountered so far using organ on a chip technology in bio/pharmaceutical research.
Bas Trietsch, chief technology officer, MIMETAS, and one of the INTERPHEX Keynote speakers in the
For more INTERPHEX 2023 video content, check






